Aurinia Pharmaceuticals Inc.
AUPH
$15.35
$0.171.12%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 37.41M | 34.36M | 210.79M | 31.55M | 21.51M |
| Total Depreciation and Amortization | 4.83M | 4.82M | 4.86M | 4.87M | 4.86M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.84M | 6.26M | -176.49M | 4.07M | 12.14M |
| Change in Net Operating Assets | 1.47M | -12.87M | 6.50M | 3.97M | 5.73M |
| Cash from Operations | 52.57M | 32.56M | 45.67M | 44.45M | 44.24M |
| Capital Expenditure | 0.00 | -39.00K | -72.00K | -65.00K | -98.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 5.21M | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 76.24M | -18.04M | -36.68M | -13.71M | -13.18M |
| Cash from Investing | 81.45M | -18.08M | -36.76M | -13.77M | -13.27M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.41M | -3.65M | -3.49M | -3.45M | -3.43M |
| Issuance of Common Stock | 58.80M | 713.00K | 1.96M | 1.99M | 1.70M |
| Repurchase of Common Stock | -50.59M | -50.75M | -364.00K | -9.04M | -42.67M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4.81M | -53.69M | -1.89M | -10.49M | -44.39M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 138.82M | -39.21M | 7.02M | 20.19M | -13.43M |